PNC Financial Services Group
GEVA

PNC Financial Services Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

PNC Financial Services Group’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-67
Closed -$7K – 4871
2015
Q1 		$7K Buy
67
+7
+12% +$741 ﹤0.01% 3941
2014
Q4 		$6K Hold
60
– – ﹤0.01% 3530
2014
Q3 		$4K Sell
60
-137
-70% -$9.81K ﹤0.01% 3552
2014
Q2 		$20K Buy
197
+137
+228% +$11.7K ﹤0.01% 2935
2014
Q1 		$5K Buy
+60
New +$5.55K ﹤0.01% 3271

PNC Financial Services Group's GEVA Position: Q2 2015 in Review

PNC Financial Services Group sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 67 shares — an estimated $7K sold.

PNC Financial Services Group first reported a position in GEVA in Q1 2014 and held it in 5 quarters. The position peaked at $20K in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • PNC Financial Services Group reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • PNC Financial Services Group sold 67 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $7K.
  • PNC Financial Services Group first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • PNC Financial Services Group's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $20K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on PNC Financial Services Group's 13F filing for Q2 2015, filed 5 Aug 2015.